CANADA@BIO 2005

Canada - Thinking Beyond Tomorrow...

World Class research in biotechnology in Canada today has the needs of tomorrow in mind.

• Canadian research is responsible for many important medical breakthroughs, including:
• Discovery of the T-Cell receptor;
• Identification of the gene that causes Cystic Fibrosis;
• Applications of photo-dynamic therapy to cancer treatment;
• Discovery of the genetic link between apolipoprotein and the most common form of Alzheimer's disease.
• The Canadian Institutes of Health Research directs funding to health research through the means of virtual institutes in 13 key areas.
• Genome Canada was created to coordinate genomics research in diverse areas across the country.
• The Canada Foundation for Innovation and the Canada Research Chairs were endowed to improve the research capabilities of universities, hospitals and laboratories.
• Canada is second to the US in the number of core biotech firms and has the largest per capita number of biotechnology companies in the world.
• Among G7 countries, Canada has the fastest rate of growth in the number of workers devoted to R&D;, in external patent applications, and in business expenditures on R&D.;
• Canada has the lowest business costs, the lowest payroll taxes and the best R&D; tax treatment in the G-7. (Sources)
• Canada is the #1 trade and investment destination, with the most highly educated workforce and the highest computer literacy rates in the G-7.

Impressive! Drop by the Canadian Pavilion's and visit over 80 exhibitors from across the country at BIO 2005 in Philadelphia, June 19-22.

Discover how Canada can help you with your future research needs today!

Keep up to date on the latest Canada@BIO 2005 news. Visit this website often.www.strategis.gc.ca/canada@bio

For additional information, please contact:

Mark Craig, Trade Team Canada Bio-Industries Coordinator
Life Sciences Branch, Industry Canada
Telephone: (902) 426-9958
E-Mail: craig.mark@ic.gc.ca